Table 3.
Multivariate analysis with Cox proportional hazard model for three survival endpoints: RFS, DMFS and MSS.
| RFS | DMFS | MSS | |||||
|---|---|---|---|---|---|---|---|
| Cohorts | Predictors | Hazard ratio (HR) | P-value | Hazard ratio (HR) | P-value | Hazard ratio (HR) | P-value |
| Entire Cohort (n=831, excluded n=6) (Events: RFS: 164 ; DMFS: 110; MSS: 48) | Breslow thickness | 1.20 (1.12 – 1.29) | <0.001 | 1.11 (1.03 – 1.19) | 0.014 | 1.17 (1.07 – 1.28) | 0.009 |
| Age | 1.02 (1.00 – 1.03) | 0.004 | 1.01 (1.00 – 1.02) | 0.156 | 1.02 (1.00 – 1.04) | 0.072 | |
| Ulceration | 1.56 (1.12 – 2.18) | 0.010 | 1.71 (1.14 – 2.57) | 0.011 | 1.64 (0.88 – 3.06) | 0.125 | |
| SLNb status | 2.28 (1.61 – 3.24) | <0.001 | 2.10 (1.37 – 3.22) | 0.001 | 1.74 (0.90 – 3.36) | 0.102 | |
| CP-GEP risk labels | 2.40 (1.53 – 3.74) | <0.001 | 2.32 (1.35 – 3.97) | 0.001 | 2.05 (0.93 – 4.54) | 0.064 | |
| SLNb negative (n=633, excluded n=4) (Events: RFS: 89; DMFS: 59; MSS: 27) | Breslow thickness | 1.31 (1.13 – 1.52) | 0.002 | 1.39 (1.16 – 1.66) | 0.002 | 1.53 (1.12 – 2.08) | 0.018 |
| Age | 1.01 (0.99 – 1.02) | 0.220 | 1.00 (0.98 – 1.02) | 0.752 | 1.03 (1.00 – 1.06) | 0.073 | |
| Ulceration | 1.45 (0.90 – 2.34) | 0.131 | 1.33 (0.74 – 2.41) | 0.349 | 1.52 (0.65 – 3.53) | 0.345 | |
| CP-GEP risk labels | 2.57 (1.53 – 4.34) | <0.001 | 2.72 (1.40 – 5.28) | 0.002 | 1.98 (0.76 – 5.16) | 0.152 | |
| Stages I-IIA (n=578, excluded n=2) (Events: RFS: 68; DMFS: 47; MSS: 21) | Breslow thickness | 1.47 (1.07 – 2.02) | 0.021 | 1.63 (1.13 – 2.37) | 0.013 | 1.23 (0.67 – 2.27) | 0.516 |
| Age | 1.01 (0.99 – 1.03) | 0.272 | 1.00 (0.98 – 1.02) | 0.642 | 1.03 (1.00 – 1.06) | 0.069 | |
| Ulceration | 0.95 (0.44 – 2.05) | 0.900 | 1.15 (0.47 – 2.80) | 0.765 | 1.20 (0.34 – 4.25) | 0.783 | |
| CP-GEP risk labels | 2.27 (1.25 – 4.12) | 0.006 | 2.29 (1.09 – 4.77) | 0.025 | 2.27 (0.79 – 6.51) | 0.123 | |